CA1005062A - Process for producing tetrahydrocarbazole derivatives - Google Patents
Process for producing tetrahydrocarbazole derivativesInfo
- Publication number
- CA1005062A CA1005062A CA172,234A CA172234A CA1005062A CA 1005062 A CA1005062 A CA 1005062A CA 172234 A CA172234 A CA 172234A CA 1005062 A CA1005062 A CA 1005062A
- Authority
- CA
- Canada
- Prior art keywords
- producing
- tetrahydrocarbazole derivatives
- tetrahydrocarbazole
- derivatives
- producing tetrahydrocarbazole
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19722226703 DE2226703A1 (en) | 1972-05-25 | 1972-05-25 | NEW TETRAHYDROCARBAZOLE DERIVATIVES AND THE PROCESS FOR THEIR PRODUCTION |
Publications (1)
Publication Number | Publication Date |
---|---|
CA1005062A true CA1005062A (en) | 1977-02-08 |
Family
ID=5846530
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA172,234A Expired CA1005062A (en) | 1972-05-25 | 1973-05-25 | Process for producing tetrahydrocarbazole derivatives |
Country Status (12)
Country | Link |
---|---|
JP (1) | JPS4941367A (en) |
AT (1) | AT323155B (en) |
AU (1) | AU5607873A (en) |
BE (1) | BE800066A (en) |
CA (1) | CA1005062A (en) |
CH (1) | CH582144A5 (en) |
CS (1) | CS179416B2 (en) |
DD (1) | DD106170A5 (en) |
DE (1) | DE2226703A1 (en) |
FR (1) | FR2185414B1 (en) |
GB (1) | GB1436893A (en) |
NL (1) | NL7307313A (en) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4235903A (en) * | 1979-08-06 | 1980-11-25 | American Home Products Corporation | 1-Hydroxyalkanamine tetrahydrocarbazoles and cyclopent[b]indoles, compositions and method of use |
US7151100B1 (en) | 1999-07-23 | 2006-12-19 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7105560B1 (en) | 1999-07-23 | 2006-09-12 | The Regents Of The University Of California | Use of etodolac in the treatment of multiple myeloma |
US6545034B1 (en) | 1999-07-23 | 2003-04-08 | The Regents Of The University Of California | Use of etodolac for the treatment of chronic lymphocytic leukemia |
US7129262B2 (en) | 1999-07-23 | 2006-10-31 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
US7361680B2 (en) | 1999-07-23 | 2008-04-22 | The Regents Of The University Of California | Indole compounds useful for the treatment of cancer |
DE10164564B4 (en) * | 2001-12-14 | 2007-05-16 | Zentaris Gmbh | Tetrahydrocarbazole derivatives as ligands for G-protein coupled receptors (GPCR) |
WO2004026116A2 (en) | 2002-09-19 | 2004-04-01 | The Regents Of The University Of California | Use of etodoclac to treat hyperplasia |
US20060074124A1 (en) * | 2003-09-12 | 2006-04-06 | Andrew Napper | Methods of treating a disorder |
EP1677794B1 (en) * | 2003-09-12 | 2014-12-03 | Elixir Pharmaceuticals, Inc. | Methods of treating disorder |
US7314886B2 (en) | 2003-10-02 | 2008-01-01 | Cephalon, Inc. | Tetrahydropyrano-indole derivatives |
KR20190004843A (en) * | 2008-07-23 | 2019-01-14 | 아레나 파마슈티칼스, 인크. | SUBSTITUTED 1,2,3,4- TETRAHYDROCYCLOPENTA[b]INDOL-3-YL) ACETIC ACID DERIVATIVES USEFUL IN THE TREATMENT OF AUTOIMMUNE AND INFLAMMATORY DISORDERS |
BRPI0917923B1 (en) | 2008-08-27 | 2022-04-05 | Arena Pharmaceuticals Inc | Substituted tricyclic acid derivative, its composition, its use and process for preparing said composition |
EP3378854B1 (en) | 2010-01-27 | 2022-12-21 | Arena Pharmaceuticals, Inc. | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
JP2013521301A (en) | 2010-03-03 | 2013-06-10 | アリーナ ファーマシューティカルズ, インコーポレイテッド | Process for the preparation of S1P1 receptor modulators and their crystalline forms |
CN116850181A (en) | 2015-01-06 | 2023-10-10 | 艾尼纳制药公司 | Treatment and S1P 1 Methods of receptor-related disorders |
MX2017016530A (en) | 2015-06-22 | 2018-03-12 | Arena Pharm Inc | Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluo romethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)a cetic acid(compound1) for use in sipi receptor-associated disorders. |
US11478448B2 (en) | 2017-02-16 | 2022-10-25 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations |
CN110520124A (en) | 2017-02-16 | 2019-11-29 | 艾尼纳制药公司 | For treating the Compounds and methods for of primary biliary cholangitis |
KR20210074291A (en) | 2018-09-06 | 2021-06-21 | 아레나 파마슈티칼스, 인크. | Compounds useful for the treatment of autoimmune and inflammatory disorders |
CN114634442B (en) * | 2022-04-02 | 2023-10-13 | 内蒙古民族大学 | Preparation method of tetrahydrocarbazolone compound |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH586678A5 (en) * | 1970-05-25 | 1977-04-15 | Hoffmann La Roche | |
ZA715217B (en) * | 1970-08-20 | 1972-04-26 | Org Nv | Anti-inflammatory preparations |
-
1972
- 1972-05-25 DE DE19722226703 patent/DE2226703A1/en active Pending
-
1973
- 1973-04-17 DD DD17023273A patent/DD106170A5/xx unknown
- 1973-05-14 GB GB2279573A patent/GB1436893A/en not_active Expired
- 1973-05-16 CS CS350973A patent/CS179416B2/en unknown
- 1973-05-17 CH CH707473A patent/CH582144A5/xx not_active IP Right Cessation
- 1973-05-23 AT AT449173A patent/AT323155B/en not_active IP Right Cessation
- 1973-05-24 AU AU56078/73A patent/AU5607873A/en not_active Expired
- 1973-05-25 BE BE131549A patent/BE800066A/en unknown
- 1973-05-25 FR FR7319087A patent/FR2185414B1/fr not_active Expired
- 1973-05-25 NL NL7307313A patent/NL7307313A/xx not_active Application Discontinuation
- 1973-05-25 JP JP5848173A patent/JPS4941367A/ja active Pending
- 1973-05-25 CA CA172,234A patent/CA1005062A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
FR2185414A1 (en) | 1974-01-04 |
GB1436893A (en) | 1976-05-26 |
CH582144A5 (en) | 1976-11-30 |
BE800066A (en) | 1973-11-26 |
DE2226703A1 (en) | 1973-12-13 |
CS179416B2 (en) | 1977-10-31 |
FR2185414B1 (en) | 1976-08-13 |
NL7307313A (en) | 1973-11-27 |
DD106170A5 (en) | 1974-06-05 |
AT323155B (en) | 1975-06-25 |
AU5607873A (en) | 1974-11-28 |
JPS4941367A (en) | 1974-04-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1005062A (en) | Process for producing tetrahydrocarbazole derivatives | |
HU171819B (en) | Process for producing 2-oxo-3-phenoxypropyl-phosphonic acid-dialkyl-ester derivatives | |
CA1021097A (en) | Process for preparing poly-ion-complexes | |
HU172069B (en) | Process for producing 1-bracket-3-disubstituted-phosphono-thioureido-bracket closed-2-bracket-3-substituted-ureidoor -thioureido-bracket closed-benzene derivatives | |
CA1030151A (en) | Process for producing 9,10-seco-oestrane derivatives | |
CA1034115A (en) | Process for producing desacetoxycephalosporin derivatives | |
CA983956A (en) | Process for preparing monoformyldiaminomaleonitrile | |
HU173381B (en) | Process for producing carboxy-cyclopropane derivatives | |
CA967976A (en) | Process for producing trimethyl-p-benzoquinone | |
CA987326A (en) | Process for producing 2-acyl-5-nitrothiazoles | |
AU476254B2 (en) | Process for producing chromone derivatives | |
CA900476A (en) | Process for producing 1-aminoalkylbenzodiazepine derivatives | |
CA894235A (en) | Process for producing 1-acylindole derivatives | |
CA894214A (en) | Process for producing l-tryptophan | |
CA903692A (en) | Process for producing l-tryptophan | |
CA903691A (en) | Process for producing l-tryptophan | |
AU459799B2 (en) | Process for producing indan derivatives | |
CA893098A (en) | Process for producing l-threonine | |
AU467691B2 (en) | Process for preparing cedrenal | |
CA980047A (en) | Process for preparing polythiodiglycol | |
CA903207A (en) | Process for producing benzodiazepine derivatives | |
CA893122A (en) | Process for producing benzodiazepine derivatives | |
CA893702A (en) | Process for producing benzodiazepine derivatives | |
CA909219A (en) | Process for producing benzodiazepine derivatives | |
CA905938A (en) | Process for producing 5-bromo-6-fluoro-steroids |